Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial |
| |
| Authors: | Feldman Steven R Kimball Alexa Boer Krueger Gerald G Woolley J Michael Lalla Deepa Jahreis Angelika |
| |
| Affiliation: | Wake Forest University School of Medicine, Winston Salem, North Carolina 27157-1071, USA. sfeldman@wfubmc.edu |
| |
| Abstract: | In this randomized, double-blind, phase III trial, patients with psoriasis received etanercept for 24 weeks or placebo for 12 weeks followed by etanercept for 12 weeks. At week 12, improvement in Dermatology Life Quality Index was 47% to 61% with etanercept compared with 11% with placebo (P < .0001). Etanercept rapidly and substantially improved patients' health-related quality of life. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
